Literature DB >> 31264989

Expression of metalloproteinase-9 in patients with mild and severe forms of gastroesophageal reflux disease.

Álvaro J Montiel-Jarquín1, Luis G Vázquez de Lara-Cisneros2, Aurelio López-Colombo1, Hugo A Solís-Mendoza1, María L Palmer-Márquez1, María S Romero-Figueroa3.   

Abstract

BACKGROUND: Gastroesophageal reflux disease develops when the stomach contents causes troublesome symptoms and complications. Mild forms are non-erosive and erosive esophagitis, and severe forms are Barrett's esophagus and Esophageal adenocarcinoma. Matrix metalloproteinases are endopeptidases that can degrade components of the extracellular matrix, they play an important role in tumor invasion as well as in metastasis.
OBJECTIVE: To correlate the expression of metalloproteinase 9 (MMP-9) in esophageal biopsies from patients with mild and severe forms of Gastroesophageal reflux disease.
METHOD: Cross-sectional study. The expression of MMP-9 was determined in biopsies of esophageal tissue of patients with mild and severe GRD. The included variables were age, sex, diagnosis, smoking and alcoholic habits, body mass index (BMI) and expression of MMP-9. Descriptive statistics was performed, Kappa for concordance in diagnosis as well as X2.
RESULTS: There were 50 patients, 32 (64%) men and 18 (36%) women, mean age 52.13 ± 14.75 years of age. 12 (24%) with smoking and 7 (14%) with alcoholism. Average BMI was 26.71 ± 4.07 kg/m2 (15 to 33); 40 (80%) with obesity. The inter observer concordance for histopathological diagnosis was 1.0 and 0.84 for esophagitis degrees. 27 (54%) patients had esophagitis, 16 (32%) Barrett's esophagus and 7 (14%) esophageal cancer. There was expression of MMP-9 in four patients with esophagitis, five with Barrett's esophagus and five with esophageal cancer. Statistical significance was found between the expression of MMP-9 and smoking (p = 0.011) and histopathological diagnosis (p = 0.052).
CONCLUSIONS: The expression of MMP-9 is most common in severe forms compared to the mild forms of GRD. Copyright:
© 2019 Permanyer.

Entities:  

Keywords:  Adenocarcinoma esofágico; Barret’s esophagus; Enfermedad por reflujo gastroesofágico; Esophageal adenocarcinoma; Esófago de Barrett; Gastroesophageal reflux disease; Metalloproteinase-9; Metaloproteinasa-9

Mesh:

Substances:

Year:  2019        PMID: 31264989     DOI: 10.24875/CIRU.18000691

Source DB:  PubMed          Journal:  Cir Cir        ISSN: 0009-7411            Impact factor:   0.361


  1 in total

1.  Herbal Medicine Hewei Jiangni Decoction Is Noninferior to Oral Omeprazole for the Treatment of Nonerosive Gastroesophageal Reflux Disease: A Randomized, Double-Blind, and Double-Dummy Controlled Trail.

Authors:  Feng Li; Yali Yuan; Di Wu; Junxiang Li; Haixiao Han; Xiaohong Li; Liming Hu; Runhua Chen; Yupu Yao; Yao Jiao; Huihui Chen; Tangyou Mao; Chune Xie
Journal:  Evid Based Complement Alternat Med       Date:  2022-09-22       Impact factor: 2.650

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.